Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Artery Thrombosis”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableUnknownNCT03730675
What this trial is testing

Irradiation Stent Placement Plus TACE for HCC and PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Zhongda Hospital 308
Testing effectiveness (Phase 2)Looking for participantsNCT07062055
What this trial is testing

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more
Shandong Cancer Hospital and Institute 54
Large-scale testing (Phase 3)UnknownNCT02971345
What this trial is testing

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Shanghai Zhongshan Hospital 253
Not applicableEnrolling By InvitationNCT05818644
What this trial is testing

Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children

Who this might be right for
Hepatic Artery ThrombosisHepatic Artery StenosisPediatric ALL+1 more
University Medical Center Groningen 400
Testing effectiveness (Phase 2)UnknownNCT06210334
What this trial is testing

HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)

Who this might be right for
Hepatocellular Carcinoma With PVTT
Li Xiao Wei 54
Not applicableLooking for participantsNCT06669377
What this trial is testing

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 444
Not applicableStudy completedNCT06265883
What this trial is testing

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 205
Large-scale testing (Phase 3)Ended earlyNCT01887717
What this trial is testing

Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 36
Testing effectiveness (Phase 2)Study completedNCT05166239
What this trial is testing

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Peking University 66
Not applicableStudy completedNCT06631326
What this trial is testing

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Who this might be right for
HCC - Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyBCLC Stage C Hepatocellular Carcinoma+2 more
First Hospital of China Medical University 244
Large-scale testing (Phase 3)UnknownNCT02301091
What this trial is testing

Combine TACE and RFA Versus TACE Alone for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Ming Zhao 240
Testing effectiveness (Phase 2)Looking for participantsNCT06031285
What this trial is testing

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 43
Large-scale testing (Phase 3)UnknownNCT03468231
What this trial is testing

HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 300
Large-scale testing (Phase 3)UnknownNCT04946929
What this trial is testing

Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT)

Who this might be right for
Hepatic Artery ThrombosisLiver Transplant; ComplicationsPediatric Disease
RenJi Hospital 50
Not applicableLooking for participantsNCT05984511
What this trial is testing

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular CarcinomaHepatic Portal Vein Tumor InvasionTumor Thrombus
Third Affiliated Hospital, Sun Yat-Sen University 234
Not applicableStudy completedNCT03098589
What this trial is testing

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Who this might be right for
Lymphoma
Celgene 1,149
Not applicableUnknownNCT03322280
What this trial is testing

TACE Combined With Iodine-125 Seeds Implantation for HCC

Who this might be right for
Hepatocellular CarcinomaPortal Vein OcclusionTumor Thrombus
Second Affiliated Hospital of Guangzhou Medical University 270
Testing effectiveness (Phase 2)UnknownNCT04947826
What this trial is testing

Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma With Major Portal Vein Thrombosis
Shanghai Zhongshan Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04945720
What this trial is testing

Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 30
Testing effectiveness (Phase 2)UnknownNCT01834963
What this trial is testing

P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular Carcinoma
Kansai Hepatobiliary Oncology Group 66
Load More Results